Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barbieri

Showing results (281-290 of 305) with videos related to

Pageof 31
Sort By:
Cancer Cell|May 16, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
JCO Precision Oncology|February 15, 2019
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate CancerDeli Liu, Mandeep Takhar, Mohammed Alshalalfa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage PlasticityDan Li, Naitao Wang, Wangxin Guo, et al.
Journal of Translational Medicine|August 17, 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsHui Wang, Christopher E Barbieri, Jintang He, et al.
The Journal of Hospital Infection|March 3, 2025
Revisiting antimicrobial stewardship in the paediatric intensive care unit: insights from an unconventional approachC Liberati, G Brigadoi, E Gres, et al.
Nature Communications|April 26, 2020
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypesDeli Liu, Jonathan E Shoag, Daniel Poliak, et al.
Nature Biotechnology|May 31, 2022
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencingAditya S Deshpande, Netha Ulahannan, Matthew Pendleton, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
JCI Insight|January 20, 2022
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer fociJacqueline Fontugne, Peter Y Cai, Hussein Alnajar, et al.
Pageof 31

Showing results (281-290 of 305) with videos related to

Sort By:
Pageof 31
Cancer Cell|May 16, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
JCO Precision Oncology|February 15, 2019
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate CancerDeli Liu, Mandeep Takhar, Mohammed Alshalalfa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage PlasticityDan Li, Naitao Wang, Wangxin Guo, et al.
Journal of Translational Medicine|August 17, 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsHui Wang, Christopher E Barbieri, Jintang He, et al.
The Journal of Hospital Infection|March 3, 2025
Revisiting antimicrobial stewardship in the paediatric intensive care unit: insights from an unconventional approachC Liberati, G Brigadoi, E Gres, et al.
Nature Communications|April 26, 2020
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypesDeli Liu, Jonathan E Shoag, Daniel Poliak, et al.
Nature Biotechnology|May 31, 2022
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencingAditya S Deshpande, Netha Ulahannan, Matthew Pendleton, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
JCI Insight|January 20, 2022
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer fociJacqueline Fontugne, Peter Y Cai, Hussein Alnajar, et al.
Pageof 31